Trials / Active Not Recruiting
Active Not RecruitingNCT07398261
Efficacy of Mirabegron for Treatment of Non-monosymptomatic Nocturnal Enuresis in Children
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 151 (estimated)
- Sponsor
- Menoufia University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This phase 3 clinical trial will compare use of individual treatment with mirabegron or desmopressin and their combination for treatment of non-monosymptomatic nocturnal enuresis in children
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mirabegron 25 MG | Evaluate the efficacy of individual mirabegron or in combination for treatment of non-monosymptomatic nocturnal enuresis in children |
Timeline
- Start date
- 2023-08-28
- Primary completion
- 2026-09-01
- Completion
- 2026-11-01
- First posted
- 2026-02-09
- Last updated
- 2026-02-09
Locations
1 site across 1 country: Egypt
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07398261. Inclusion in this directory is not an endorsement.